Second, the cross-regulatory mechanisms linking IGF signaling with other key PAH pathways, such as BMP/TGF-β and HIF-1α, are poorly characterized, limiting our understanding of how these pathways converge to drive pulmonary vascular remodeling. Here, IGF1 is linked to pulmonary arterial hypertension.